MorningMed is a community of 814,300 medical professionals

We're a place where medical professionals share news and other news items to help their peers stay up to date

All articles tagged: Mantle cell lymphoma (C83.1)

Evalytics 25 March at 05.57 AM

Some lymphomas become resistant to treatment. Gene discovery may offer path to overcome it.

University of Wisconsin–Madison researchers have uncovered a critical process driving resistance in certain types of lymphoma, offering hope for patients who become resistant to standard treatments. The study focused on understanding why some patients with B-cell malignancies, such as mantle cell lymphoma and diffuse large B-cell lymphoma, develop resistance to Bruton tyrosine kinase inhibitors (B

HealthDay 21 December at 04.47 PM

American Society of Hematology, Dec. 9 to 12

The annual meeting of the American Society of Hematology was held from Dec. 9 to 12 in San Diego and attracted participants from around the world, including hematology specialists as well as clinical practitioners and other health care professionals. The conference featured presentations focusing on the diagnosis, treatment, and

HealthDay 14 December at 05.00 PM

ASH: Ibrutinib-Venetoclax Beneficial for Relapsed/Refractory Lymphoma

For patients with relapsed/refractory (R/R) mantle cell lymphoma (MCL), ibrutinib combined with venetoclax provides a progression-free survival benefit, according to a study presented at the annual meeting of the American Society of Hematology, held from Dec. 9 to 12 in San Diego.Michael Wang, M.D., from the University of Texas MD Anderson Can